Thursday, July 10, 2008
« MCCAIN, OBAMA REPS DISCUSS EDUCATION | Main | FDA May 2008 Drug Safety-Related Labelin... »
FDA Herceptin 440mg Vials & BWFI
Genentech informed healthcare professionals that an increased number of complaints were received regarding damaged and broken vials of Herceptin 440 mg and BWFI (bacteriostatic water for injection) diluent. The affected vials are NDC# 50242-0134-68, List # 15534. There is a risk that damaged vials may lead to a loss in sterility, which can cause infections in patients.

Healthcare professionals should inspect cartons of the product for signs of leakage, cracks and other damage to the vials, observe the vials during reconstitution, and check for loss of vacuum in the vials. See the manufacturer's letter for specific details and recommendations, including instructions in the event a compromised vial is discovered.

Read the entire 2008 MedWatch Safety Summary, including a link to the manufacturer's Dear Healthcare Professional Letter regarding this issue at:  

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Herceptin

NetHappenings Mailing List | Science
Thursday, July 10, 2008 8:33:51 PM (Eastern Daylight Time, UTC-04:00)    Disclaimer  |  Comments [0]  |  Related posts:
Carnegie Mellon System Thwarts Internet Eavesdropping
Speed Matters
Google Spy
It takes style to call hogs and hubbies
"'wot do U tink?' (What Do You Think?)"
K-12 Newsletter GRANTS AND FUNDING
Comments are closed.